Small Biotechs Could Suffer Under State Bans On Selling Physician Rx Data, BIO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Bans on the practice, like the recently upheld New Hampshire law, could have an unintended financial consequence on small biotech companies, BIO warns.
You may also be interested in...
With Ban On Prescribing Data In Effect In N.H., IMS/SDI Petition Supreme Court
IMS and SDI are seeking a Supreme Court review of a N.H. law banning the sale of physician prescribing data.
With Ban On Prescribing Data In Effect In N.H., IMS/SDI Petition Supreme Court
IMS and SDI are seeking a Supreme Court review of a N.H. law banning the sale of physician prescribing data.
Rx Datamining Ban By N.H. Upheld On Appeal; Will Other States Follow?
New Hampshire's appeals court win in a case challenging its law that bans the sale of physician prescribing data could encourage other states to enact similar legislation